Class Action Alert: Protecting APLT Shareholder Rights

Class Action Alert for APLT Shareholders

The Gross Law Firm is reaching out to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT) with significant news regarding a class action lawsuit. This lawsuit may provide an opportunity for investors affected by recent developments to seek justice and recover losses sustained during the designated class period.

Understanding the Class Period

Shareholders who purchased shares of APLT from early January 2024 to early December 2024 are especially encouraged to come forward. This period witnessed tumultuous challenges for Applied Therapeutics, leading to drastic shifts in the stock price that directly impacted investors.

The Allegations Against Applied Therapeutics

On November 27, 2024, Applied Therapeutics made an announcement that reverberated through the market: they received a Complete Response Letter (CRL) concerning their New Drug Application (NDA) for the drug candidate, govorestat. The FDA highlighted deficiencies in the clinical data, which raised serious concerns about the company’s compliance and clinical trial processes.

Following this revelation, there was a significant and alarming decline in the stock price of Applied Therapeutics. After closing at **$10.21** on November 26, 2024, the stock plummeted, closing at **$8.57** the next day. The downward trend continued, with shares dropping to **$2.03** by November 29, 2024, and ultimately reaching **$1.75** by December 2, 2024 — a staggering over 80% loss.

The FDA’s Warning Letter

Moreover, on December 2, 2024, after the market had closed, the company disclosed that it received a warning letter from the FDA. This letter referenced serious issues related to its clinical trials, compounding the fallout from the CRL. Post-announcement, shares fell further to **$1.69** on December 3, **$1.38** on December 4, and **$1.29** on December 5, reinforcing the gravity of the situation.

Important Registration Deadline

As the situation develops, shareholders should not hesitate to register for this class action. The **deadline for registering** is **February 18, 2025**. Those who register will gain access to portfolio monitoring software, which will keep them updated on the case's progress. Remember, you do not need to become a lead plaintiff to participate in the recovery effort.

Why Engage with The Gross Law Firm?

The Gross Law Firm is dedicated to advocating for investors who have suffered losses due to misleading or deceitful corporate actions. Their mission is to ensure that companies uphold ethical business practices while protecting shareholders' rights. They strive for accountability when companies fail to provide accurate, material information, leading to unjustifiable inflation of stock prices.

How to Contact The Gross Law Firm

If you believe you are a shareholder affected by the events surrounding APLT, contacting The Gross Law Firm is a crucial step. They are positioned to assist you in navigating this complex legal landscape. You can reach them at:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (646) 453-8903

Frequently Asked Questions

What is the purpose of this class action lawsuit?

This class action lawsuit aims to represent shareholders of Applied Therapeutics who experienced financial losses due to alleged misleading statements made by the company.

When is the deadline for shareholders to register?

The deadline for shareholders to register for this class action is February 18, 2025.

What losses can shareholders potentially recover?

Shareholders may potentially recover losses sustained due to the decline in APLT's stock price related to the disclosures made by the company regarding their drug application.

Do shareholders need to be lead plaintiffs to participate?

No, shareholders do not need to be appointed as lead plaintiffs to partake in any recovery from the class action.

How can I stay updated on the case?

Upon registration, shareholders will receive updates through portfolio monitoring software that provides current status on the case.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. If any of the material offered here is inaccurate, please contact us for corrections.